Alexander, Jordan D.
Linkersdörfer, Janosch
Toda-Thorne, Katherine
Sullivan, Ryan M.
Cummins, Kevin M.
Tomko, Rachel L.
Allen, Nicholas B.
Bagot, Kara S.
Baker, Fiona C.
Fuemmeler, Bernard F.
Hoffman, Elizabeth A.
Kiss, Orsolya
Mason, Michael J.
Nguyen-Louie, Tam T.
Tapert, Susan F.
Smith, Calen J.
Squeglia, Lindsay M.
Wade, Natasha E.
Funding for this research was provided by:
National Institute on Drug Abuse (T32 DA050560)
NIDA (K08 DA050779)
Article History
Received: 11 April 2024
Accepted: 24 July 2024
First Online: 3 August 2024
Competing interests
: N.B. Allen holds an equity interest in Ksana Health, which produces commercial licenses for the EARS software that was used in this manuscript. No other authors have any competing interests to disclose.